Group One Trading
VERA icon

Group One Trading’s Vera Therapeutics VERA Stock Holding History

Group One Trading’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Sell
6,300
-32,300
-84% -$1.2M ﹤0.01% 4044
2026
Q1 		$1.55M Buy
38,600
+28,900
+298% +$1.25M ﹤0.01% 2298
2025
Q4 		$491K Buy
9,700
+3,600
+59% +$128K ﹤0.01% 3534
2025
Q3 		$177K Sell
6,100
-18,200
-75% -$421K ﹤0.01% 4793
2025
Q2 		$573K Buy
24,300
+12,900
+113% +$290K ﹤0.01% 3275
2025
Q1 		$274K Buy
11,400
+10,000
+714% +$321K ﹤0.01% 3698
2024
Q4 		$59.2K Sell
1,400
-44,600
-97% -$1.97M ﹤0.01% 4929
2024
Q3 		$2.03M Buy
+46,000
New +$1.75M 0.01% 1699
2024
Q2 		– Sell
-14,000
Closed -$604K – 7549
2024
Q1 		$604K Buy
14,000
+11,500
+460% +$410K ﹤0.01% 2555
2023
Q4 		$38.5K Sell
2,500
-600
-19% -$7.62K ﹤0.01% 5265
2023
Q3 		$42.5K Buy
3,100
+2,700
+675% +$46.3K ﹤0.01% 5257
2023
Q2 		$6.42K Buy
+400
New +$3.61K ﹤0.01% 6601

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Group One Trading's VERA Position: Q2 2026 in Review

Group One Trading opened a new position in Vera Therapeutics (VERA) in Q2 2026: 68,098 shares worth $2.92M. The stake represents ﹤0.01% of the portfolio and ranks #1861 among its holdings. This is a return to the name: Group One Trading previously reported a position in VERA as recently as Q2 2025.

Group One Trading first reported a position in VERA in Q2 2024 and has held it in 4 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Group One Trading held 68,098 shares of Vera Therapeutics worth $2.92M as of Q2 2026.
  • Vera Therapeutics was a new Group One Trading position in Q2 2026.
  • Vera Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #1861 holding.
  • Group One Trading first reported a position in Vera Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.